RVP logo

Retractable Technologies (RVP) Company Overview

Profile

Full Name:

Retractable Technologies, Inc.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

United States

IPO:

May 4, 2001

Indexes:

Not included

Website:

http://www.retractable.com

Description:

Retractable Technologies, Inc. (RVP) specializes in developing and manufacturing safety medical devices, particularly retractable syringes and needles. Their products aim to reduce needlestick injuries and enhance safety for healthcare workers and patients. The company focuses on innovation and quality in the medical device industry.

Key Details

Price

$0.83

Market Cap

$24.85 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$43.60 M(-54.02% YoY)

Annual EPS

-$0.24(-260.00% YoY)

PE Ratio

-

Annual ROE

-6.81%

Annual Debt To Equity

0.02

Beta

0.68

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with RVP included

Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Best performing stocks last 3 months
Stocks above SMA 50
Healthcare sector
All stocks
Biggest stock gainers today
Small cap stocks
Moving average channel strategy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.83
RVP price is $0.83

Price All-time High

$21.50
RVP price is currently -96.14% below its historical high of $21.50

Price Analysts Target

-
RVP price consensus analysts' forecast is unknown

Price Most Recent Change

+9.21%
RVP price was up +9.21% on Mar 3, 2025

Price YTD Change

+24.61%
RVP price is up +24.61% since January 1st

Price 3-Year Change

-82.49%
RVP price is down -82.49% over the past 3 years

Market cap

Market Cap

$24.85 M
RVP market capitalization is $24.85 million

Market Cap 3-Year Change

-84.34%
RVP market capitalization is down -84.34% over the past 3 years

Market Cap All-time High

$730.08 M
RVP market capitalization is currently -96.60% below its historical high of $730.08 million

Market Cap Sector Rank

28.07%
RVP market capitalization is higher than 28.07% of companies in Healthcare sector

Technical

Beta

0.68
RVP beta is 0.68

200-day SMA

$0.87
RVP price is currently -4.70% below its 200-day simple moving average

14-day RSI

50.75
RVP 14-day relative strength index is 50.75

30-day Relative Volume

0.78
RVP 30-day relative volume is 0.78

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$43.60 M
RVP annual revenue is $43.60 million

Annual Revenue Analysts Estimate

-
RVP annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-54.02%
RVP annual revenue is down -54.02% year-on-year

Annual Revenue Sector Rank

45.34%
RVP annual revenue is higher than 45.34% of companies in Healthcare sector

Profit

Annual Gross Profit

$9.11 M
RVP annual gross profit is $9.11 million

Annual Gross Margin

20.89%
RVP annual gross profit margin is 20.89%

Annual Operating Profit

-$5.26 M
RVP annual operating income is -$5.26 million

Annual Operating Margin

-12.08%
RVP annual operating profit margin is -12.08%

Annual Net Income

-$7.01 M
RVP annual net profit is -$7.01 million

Annual Net Margin

-16.08%
RVP annual net profit margin is -16.08%

EPS

Annual EPS

-$0.24
RVP annual earnings per share is -$0.24

Annual EPS Analysts Estimate

-
RVP annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-260%
RVP annual earnings per share is down -260% year-on-year

Annual EPS Sector Rank

76.91%
RVP annual earnings per share is higher than 76.91% of companies in Healthcare sector

ROA & ROE

Annual ROA

-3.74%
RVP annual return on assets is -3.74%

Annual ROE

-6.81%
RVP annual return on equity is -6.81%

EBIT & EBITDA

Annual EBIT

-$8.76 M
RVP annual earnings before interest & taxes is -$8.76 million

Annual EBITDA

-$1.24 M
RVP annual EBITDA is -$1.24 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
RVP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
RVP price to earnings ratio is unknown

PB Ratio

PB Ratio

0.30
RVP price to book ratio is 0.30

PB Ratio Sector Rank

21.86%
RVP price to book ratio is higher than 21.86% of companies in Healthcare sector

PS Ratio

PS Ratio

0.65
RVP price to sales ratio is 0.65

PS Ratio Sector Rank

18.38%
RVP price to sales ratio is higher than 18.38% of companies in Healthcare sector

Enterprise value

Enterprise Value

$22.24 M
RVP enterprise value is $22.24 million

Enterprise Value Sector Rank

30.92%
RVP enterprise value is higher than 30.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

124.54
RVP EV/EBITDA is 124.54

EV/EBITDA Sector Rank

98.77%
RVP EV/EBITDA is higher than 98.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

8.28
RVP annual current ratio is 8.28

Annual Quick Ratio

6.41
RVP annual quick ratio is 6.41

Leverage

Annual Debt To Equity

0.02
RVP annual debt to equity ratio is 0.02

Annual Interest Coverage Ratio

-57.58
RVP annual interest coverage ratio is -57.58

Risk & Stability

Piotroski F-Score

5
RVP piotroski f-score is 5

Altman Z-Score

1.03
RVP altman z-score is 1.03

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$179.67 M
RVP annual total assets is $179.67 million

Annual Non Current Assets

$102.02 M
RVP annual long term assets is $102.02 million

Annual Current Assets

$77.65 M
RVP annual total current assets is $77.65 million

Annual Cash & Cash Equivalents

$12.67 M
RVP annual cash & cash equivalents is $12.67 million

Equity

Annual Book Value

$99.06 M
RVP annual book value is $99.06 million

Annual Working Capital

$68.27 M
RVP annual working capital is $68.27 million

Liabilities

Annual Total Liabilities

$80.38 M
RVP annual total liabilities is $80.38 million

Annual Total Long Term Liabilities

$71.01 M
RVP annual total long term liabilities is $71.01 million

Annual Current Liabilities

$9.38 M
RVP annual total current liabilities is $9.38 million

Annual Accounts Payable

$4.78 M
RVP annual accounts payable is $4.78 million

Debt

Annual Total Debt

$1.54 M
RVP annual total debt is $1.54 million

Annual Total Debt 1-Year Change

-15.49%
RVP annual total debt is down -15.49% year-on-year

Annual Long Term Debt

$1.23 M
RVP annual long term debt is $1.23 million

Annual Short Term Debt

$304.00 K
RVP annual short term debt is $304.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$48.86 M
RVP annual total expenses is $48.86 million

Annual Operating Expenses

$14.37 M
RVP annual total operating expenses is $14.37 million

Annual Cost Of Goods Sold

$34.49 M
RVP annual cost of goods sold is $34.49 million

Annual SGA

$20.01 M
RVP annual SGA is $20.01 million

Annual D&A

$7.53 M
RVP annual depreciation & amortization is $7.53 million

Annual Interest Expense

$152.20 K
RVP annual interest expense is $152.20 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$2.77 M
RVP annual cash flow from operations is $2.77 million

Annual CFO 1-Year Change

-83.5%
RVP annual cash flow from operations is down -83.5% year-on-year

Annual CFI

-$10.76 M
RVP annual cash flow from investing activities is -$10.76 million

Annual CFI 1-Year Change

+65.51%
RVP annual cash flow from investing activities is up +65.51% year-on-year

Annual CFF

$941.60 K
RVP annual cash flow from financing activities is $941.60 thousand

Annual CFF 1-Year Change

-81.14%
RVP annual cash flow from financing activities is down -81.14% year-on-year

Free CashFlow

Annual FCF

$1.91 M
RVP annual free cash flow is $1.91 million

Annual FCF 1-Year Change

+3191.92%
RVP annual free cash flow is up +3191.92% year-on-year

CAPEX

Annual CAPEX

$853.00 K
RVP annual capital expenditures is $853.00 thousand

Annual CAPEX 1-Year Change

-94.93%
RVP annual capital expenditures is down -94.93% year-on-year

Institutional Ownership

Similar stocks

CRIS logo
Curis (CRIS)
AKTX logo
Akari Therapeutics (AKTX)
MBOT logo
Microbot Medical (MBOT)
NRXP logo
NRx Pharmaceuticals (NRXP)
EQ logo
Equillium (EQ)
CVM logo
CEL-SCI (CVM)
ONMD logo
OneMedNet (ONMD)
NRSN logo
NeuroSense Therapeutics (NRSN)
Abpro (ABP)

FAQ

  • What is the ticker symbol for Retractable Technologies?
  • Does Retractable Technologies pay dividends?
  • What sector is Retractable Technologies in?
  • What industry is Retractable Technologies in?
  • What country is Retractable Technologies based in?
  • When did Retractable Technologies go public?
  • Is Retractable Technologies in the S&P 500?
  • Is Retractable Technologies in the NASDAQ 100?
  • Is Retractable Technologies in the Dow Jones?
  • When was Retractable Technologies's last earnings report?
  • When does Retractable Technologies report earnings?

What is the ticker symbol for Retractable Technologies?

The ticker symbol for Retractable Technologies is NYSE American:RVP

Does Retractable Technologies pay dividends?

No, Retractable Technologies does not pay dividends

What sector is Retractable Technologies in?

Retractable Technologies is in the Healthcare sector

What industry is Retractable Technologies in?

Retractable Technologies is in the Medical Instruments & Supplies industry

What country is Retractable Technologies based in?

Retractable Technologies is headquartered in United States

When did Retractable Technologies go public?

Retractable Technologies's initial public offering (IPO) was on May 4, 2001

Is Retractable Technologies in the S&P 500?

No, Retractable Technologies is not included in the S&P 500 index

Is Retractable Technologies in the NASDAQ 100?

No, Retractable Technologies is not included in the NASDAQ 100 index

Is Retractable Technologies in the Dow Jones?

No, Retractable Technologies is not included in the Dow Jones index

When was Retractable Technologies's last earnings report?

Retractable Technologies's most recent earnings report was on Nov 14, 2024

When does Retractable Technologies report earnings?

The next expected earnings date for Retractable Technologies is Mar 28, 2025